BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21176010)

  • 1. Drugs and toxins-associated pulmonary arterial hypertension: lessons learned and challenges ahead.
    de Jesus Perez V; Kudelko K; Snook S; Zamanian RT
    Int J Clin Pract Suppl; 2011 Jan; (169):8-10. PubMed ID: 21176010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug induced pulmonary hypertension].
    Sato N; Nakanishi N
    Nihon Rinsho; 2001 Jun; 59(6):1197-202. PubMed ID: 11411136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal pulmonary arterial hypertension associated with phenylpropanolamine exposure.
    Barst RJ; Abenhaim L
    Heart; 2004 Jul; 90(7):e42. PubMed ID: 15201268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary arterial hypertension due to the use of amphetamines as drugs or doping].
    van Wolferen SA; Vonk Noordegraaf A; Boonstra A; Postmus PE
    Ned Tijdschr Geneeskd; 2005 Jun; 149(23):1283-8. PubMed ID: 15960135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs induced pulmonary arterial hypertension.
    Seferian A; Chaumais MC; Savale L; Günther S; Tubert-Bitter P; Humbert M; Montani D
    Presse Med; 2013 Sep; 42(9 Pt 2):e303-10. PubMed ID: 23972547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced pulmonary arterial hypertension: a review.
    Garg L; Akbar G; Agrawal S; Agarwal M; Khaddour L; Handa R; Garg A; Shah M; Patel B; Dalal BD
    Heart Fail Rev; 2017 May; 22(3):289-297. PubMed ID: 28417295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary pulmonary hypertension].
    Rivier JL
    Schweiz Rundsch Med Prax; 1970 Apr; 59(14):503-5. PubMed ID: 5509511
    [No Abstract]   [Full Text] [Related]  

  • 8. Temporal trends and drug exposures in pulmonary hypertension: an American experience.
    Walker AM; Langleben D; Korelitz JJ; Rich S; Rubin LJ; Strom BL; Gonin R; Keast S; Badesch D; Barst RJ; Bourge RC; Channick R; Frost A; Gaine S; McGoon M; McLaughlin V; Murali S; Oudiz RJ; Robbins IM; Tapson V; Abenhaim L; Constantine G
    Am Heart J; 2006 Sep; 152(3):521-6. PubMed ID: 16923424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Appetite depressants and pulmonary hypertension].
    Hellermann J; Salomon F
    Ther Umsch; 1998 Sep; 55(9):548-50. PubMed ID: 9789468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary arterial hypertension].
    Jaïs X; Sitbon O; Savale L; Montani D; Humbert M; Simonneau G
    Rev Prat; 2008 Nov; 58(18):1997-2010. PubMed ID: 19143271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amphetamine appetite suppressant saga.
    Prescrire Int; 2004 Feb; 13(69):26-9. PubMed ID: 15055225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valve disease and pulmonary arterial hypertension due to appetite suppressants (update).
    Prescrire Int; 2000 Feb; 9(45):211. PubMed ID: 11503800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iatrogenic pulmonary artery hypertension].
    Weitzenblum E; Kessler R; Chaouat A
    Rev Mal Respir; 1996; 13(2):133-9. PubMed ID: 8711232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet drugs and pulmonary hypertension.
    Havron MD
    J Fam Pract; 1996 Nov; 43(5):434-5. PubMed ID: 8917134
    [No Abstract]   [Full Text] [Related]  

  • 15. Appetite-suppressant drugs and primary pulmonary hypertension.
    Williamson DF
    N Engl J Med; 1997 Feb; 336(7):512; author reply 512-3. PubMed ID: 9019653
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension.
    Montani D; Savale L; Natali D; Jaïs X; Herve P; Garcia G; Humbert M; Simonneau G; Sitbon O
    Eur Heart J; 2010 Aug; 31(15):1898-907. PubMed ID: 20543192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appetite-suppressant drugs and primary pulmonary hypertension.
    Dhurandhar NV; Atkinson RL
    N Engl J Med; 1997 Feb; 336(7):511-2; author reply 512-3. PubMed ID: 9019652
    [No Abstract]   [Full Text] [Related]  

  • 18. Appetite-suppressant drugs and primary pulmonary hypertension.
    Hoffman RM; Upson D
    N Engl J Med; 1997 Feb; 336(7):511; author reply 512-3. PubMed ID: 9019651
    [No Abstract]   [Full Text] [Related]  

  • 19. [The time factor in the course of primary vascular pulmonary hypertension].
    Blankart R
    Schweiz Med Wochenschr; 1970 Dec; 100(50):2157-8. PubMed ID: 5526153
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary pulmonary hypertension and anorectic drugs.
    Louis WJ
    N Engl J Med; 1999 Feb; 340(6):480-2. PubMed ID: 9988623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.